PharmaBoardroom

Patents: A Key Factor in Winning the Cannabis Arms Race

A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial for companies hoping to succeed in…

The “CDP” Cure for Common “Rx” Marketing

Meghann Chilcott offers an introductory look at the potential of customer data platforms (CDPs) to transform the way pharmacy marketers reach out to…

Value Based Care: In Need of More Patient and Physician Voices

Carla Smith outlines the role that a value-based care (VBC) approach can have on both reducing healthcare costs and improving overall care delivery to…

Let’s Treat Cannabis Like the Medicine It’s Been For Over…

David Bearman makes the historical case to be once again considered as a medicine across the USA, noting that economic – rather than health –…

The US Generic Drug Supply Chain: “Standardized,…

Chip Davis is head of the Association for Accessible Medicines (AAM) which advocates for greater uptake of generic and biosimilar drugs in the USA.…

Taiwan-US Research Team in MERS ‘Camel Flu’ Vaccine…

Researchers from Taiwan and the USA may have found a vaccine for the Middle East respiratory syndrome coronavirus (MERS-CoV) – a deadly emerging…

Technology Convergence in the Digital Era: What Implications for…

Pierre Meulien of the Innovative Medicines Initiative (IMI) discusses the potential impact that new technological innovations will have on the drug…

Taming the ‘Wild West’ of CBD

Monica Weldon looks at the history of medicinal CBD, its current usages in the USA, and why robust scientific research on its efficacy need to be…

Olivier Laureau – President, Servier Group

Olivier Laureau, global president of Servier Group, outlines the impact of recent acquisitions, the significance of Servier’s recently-opened…

Jessica Federer – Advisor, Hugo Health, USA

Jessica Federer, advisor at Hugo Health and one of the speakers at the upcoming FT US Pharma and Biotech Summit, discusses some of the key trends…

AI in Clinical Trials: Improving Efficiency, Reducing Costs

Paul Bleicher, CEO at OptumLabs, and one of the speakers at the FT US Pharma & Biotech Summit on May 14, shares insights on the benefits we will…

David Mitchell – Founder, Patients for Affordable Drugs,…

David Mitchell, founder of Patients for Affordable Drugs, looks at the US pharmaceutical industry from the patients’ perspective. This is…

Tagged with US